Angina Pectoris
📧 Sign up to get email alerts when something new happens for Angina Pectoris.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-08-29FDA Approved: BISOPROLOL FUMARATE — Supplemental Application (NorthStar Rx LLC)
FDA approved NorthStar Rx LLC's supplemental application for bisoprolol fumarate, confirming approval of a generic product. The approval per…
-
CLINICAL_TRIALS trial_result · 2011-08-26Clinical Trial Update: Effects of Low Frequency Magnetic Field on Exercise Induced Angina
A clinical trial sponsored by Aerotel Ltd is evaluating the effect of low-frequency magnetic field therapy on exercise-induced angina; curre…
-
FDA approval · 2011-08-17FDA Approved: TENORMIN — Supplemental Application (Almatica Pharma LLC)
FDA approved a supplemental application for Tenormin (atenolol) from Almatica Pharma LLC.
-
CLINICAL_TRIALS trial_result · 2011-08-05Clinical Trial Update: The Effect of Mobilized Stem Cell by G-CSF and VEGF Gene Therapy in Patients With Stable Severe Angina Pectoris [Phase 1, Phase 2]
A Phase 1/2 trial evaluated mobilized stem cell therapy using G-CSF and VEGF gene therapy in patients with stable severe angina due to ische…
-
FDA approval · 2011-08-03FDA Approved: VERAPAMIL HYDROCHLORIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved verapamil hydrochloride as an original application generic drug by Glenmark; the product is indicated for conditions treated by…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-07-27FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Teva Pharmaceuticals, Inc.)
FDA approved a supplemental application for amlodipine besylate from Teva Pharmaceuticals, Inc. under an ANDA.
-
FDA approval · 2011-07-21FDA Approved: NITROSTAT — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Nitrostat (nitroglycerin) submitted by Viatris Specialty LLC.
-
CLINICAL_TRIALS trial_result · 2011-06-22Clinical Trial Update: Stem Cell Study for Patients With Heart Disease [Phase 1, Phase 2]
The stem cell therapy trial for heart disease in Phase 1/Phase 2 has been terminated.
-
FDA approval · 2011-06-03FDA Approved: ISOSORBIDE MONONITRATE — Original Application (Torrent Pharmaceuticals Limited)
The FDA approved a generic isosorbide mononitrate product from Torrent Pharmaceuticals Limited via an original application.
-
FDA approval · 2011-06-03FDA Approved: ISOSORBIDE MONONITRATE — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited’s Original Application for Isosorbide Mononitrate, a generic nitrate used to prevent angina pec…
-
CLINICAL_TRIALS trial_result · 2011-05-13Clinical Trial Update: A Study to Treat Patients Whose Chronic Angina Symptoms Are Not Relieved by Medication and Have an Area of the Heart That Cannot be Treated by Standard Therapies [Phase 2]
GenVec-sponsored Phase 2 trial for patients with moderate-to-severe angina pectoris not relieved by standard therapies has completed. The sn…
-
FDA label_change · 2011-05-09FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)
The FDA approved a supplemental application for Norvasc (amlodipine besylate) filed by Viatris Specialty LLC. This action updates the produc…
-
FDA approval · 2011-04-29FDA Approved: ISOSORBIDE MONONITRATE — Supplemental Application (Edenbridge Pharmaceuticals LLC.)
The FDA approved a supplemental application for Isosorbide Mononitrate submitted by Edenbridge Pharmaceuticals LLC.
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: Study of Osteopathic Manipulation in the Management of Angina [NA]
Completed clinical trial evaluating osteopathic manipulation for management of angina pectoris.
-
CLINICAL_TRIALS trial_result · 2011-03-23Clinical Trial Update: Aspirin Non-responsiveness and Clopidogrel Endpoint Trial. [Phase 4]
This Phase 4 trial evaluating aspirin non-responsiveness and a clopidogrel endpoint has completed.
-
FDA approval · 2011-03-22FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (PD-Rx Pharmaceuticals, Inc.)
FDA approved a supplemental application for amlodipine besylate (PD-Rx Pharmaceuticals, Inc.) under an ANDA. This action updates the approve…
-
FDA approval · 2011-03-17FDA Approved: INDERAL LA — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Inderal LA (propranolol hydrochloride) filed by ANI Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2011-03-08Clinical Trial Update: Evaluation of Graft Material in Coronary Artery Bypass Grafting (CABG) [NA]
A completed clinical trial evaluating a graft material used in coronary artery bypass grafting, in patients with angina pectoris.
-
FDA approval · 2011-02-11FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Cipla USA Inc.)
FDA approved a supplemental application for amlodipine besylate from Cipla USA Inc., representing a supplemental approval for a generic prod…
-
FDA approval · 2011-02-07FDA Approved: CARDENE IV — Supplemental Application (Baxter Healthcare Corporation)
FDA approved a supplemental application for CARDENE IV (nicardipine hydrochloride) from Baxter Healthcare Corporation, related to the IV for…
-
FDA approval · 2011-01-27FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Diltiazem Hydrochloride from Teva Pharmaceuticals USA, Inc., updating the product's regulato…
-
FDA approval · 2011-01-20FDA Approved: DILTIAZEM HYDROCHLORIDE — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for diltiazem hydrochloride (Apotex Corp.), a generic calcium channel blocker. The approval covers t…
-
FDA approval · 2010-11-23FDA Approved: CARDIZEM LA — Supplemental Application (Bausch Health US LLC)
FDA's entry shows a supplemental application submission for Cardizem LA (diltiazem hydrochloride extended-release). The sponsor is Bausch He…
-
FDA approval · 2010-11-22FDA Approved: CARDIZEM CD — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental NDA for Cardizem CD (diltiazem hydrochloride) submitted by Bausch Health US LLC.
-
FDA approval · 2010-10-25FDA Approved: METOPROLOL — Original Application (Fresenius Kabi USA, LLC)
FDA approved the original ANDA for metoprolol tartrate by Fresenius Kabi USA, LLC, a generic beta-blocker. It is indicated for hypertension,…